SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-21-000738
Filing Date
2021-02-16
Accepted
2021-02-16 16:23:49
Documents
1
Group Members
ROBERTO MIGNONE

Document Format Files

Seq Description Document Type Size
1 bridger-atra123120a2.htm SC 13G/A 72594
  Complete submission text file 0001172661-21-000738.txt   74250
Mailing Address 90 PARK AVENUE, 40TH FLOOR NEW YORK NY 10016
Business Address 90 PARK AVENUE, 40TH FLOOR NEW YORK NY 10016 212-918-0820
BRIDGER MANAGEMENT, LLC (Filed by) CIK: 0001166309 (see all company filings)

IRS No.: 582553507 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88393 | Film No.: 21638977
SIC: 2836 Biological Products, (No Diagnostic Substances)